Solara Active Pharma Sciences has informed that the exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 10, 2024 for SRJR Enterprise LLP & PACs.
The above information is a part of company’s filings submitted to BSE.